Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Authors: Sherene Loi, Stefan Michiels, Roberto Salgado, Nicolas Sirtaine, Vinu José, Debora Fumagalli, Pirkko Kellokumpu‐Lehtinen, Petri Bono, Vesa Kataja, Christine Desmedt, Martine Piccart, Sibylle Loibl, Carsten Denkert, Mark J. Smyth, Heikki Joensuu, Christos Sotiriou - Annals of Oncology 2014 cited by 1,270